We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$4.93B
AUM Growth
+$634M
Cap. Flow
+$193M
Cap. Flow %
3.91%
Top 10 Hldgs %
46.72%
Holding
190
New
7
Increased
53
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$17.4M
2
AJG icon
Arthur J. Gallagher & Co
AJG
+$13.1M
3
RUSHA icon
Rush Enterprises Class A
RUSHA
+$11.4M
4
CACC icon
Credit Acceptance
CACC
+$10.8M
5
OWL icon
Blue Owl Capital
OWL
+$10.2M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$6.79M
2
TCN
Tricon Residential Inc.
TCN
+$6.04M
3
SHW icon
Sherwin-Williams
SHW
+$3.09M
4
AAPL icon
Apple
AAPL
+$2.49M
5
JEF icon
Jefferies Financial Group
JEF
+$1.82M

Sector Composition

Rank Sector Weight
1 Financials 40.58%
2 Healthcare 13.65%
3 Technology 12.84%
4 Industrials 7.53%
5 Communication Services 6.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JEF icon
26
Jefferies Financial Group
JEF
$12.7B
$74.8M 1.52%
1,696,418
-43,730
-3% -$1.82M
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.1T
$72M 1.46%
171,268
-4,568
-3% -$1.8M
QCOM icon
28
Qualcomm
QCOM
$164B
$70.3M 1.43%
415,278
-5,550
-1% -$858K
SHW icon
29
Sherwin-Williams
SHW
$84.8B
$62.6M 1.27%
180,364
-9,684
-5% -$3.09M
RUSHA icon
30
Rush Enterprises Class A
RUSHA
$6.34B
$54.4M 1.1%
1,015,513
+240,777
+31% +$11.4M
MA icon
31
Mastercard
MA
$498B
$50M 1.01%
103,851
+5,011
+5% +$2.29M
MKL icon
32
Markel Group
MKL
$25.2B
$47.7M 0.97%
31,350
-36
-0.1% -$52.8K
UNP icon
33
Union Pacific
UNP
$174B
$43.3M 0.88%
175,913
-2,832
-2% -$697K
JNJ icon
34
Johnson & Johnson
JNJ
$640B
$42.1M 0.85%
266,442
-6,942
-3% -$1.1M
WAB icon
35
Wabtec
WAB
$49.3B
$41.8M 0.85%
286,935
-6,064
-2% -$821K
LOW icon
36
Lowe's Companies
LOW
$121B
$39.7M 0.8%
155,727
-731
-0.5% -$168K
GSAT icon
37
Globalstar
GSAT
$10.1B
$27.1M 0.55%
1,227,699
-1,667
-0.1% -$40.4K
TEVA icon
38
Teva Pharmaceuticals
TEVA
$40.4B
$26.7M 0.54%
1,893,491
-538,723
-22% -$6.79M
BN icon
39
Brookfield
BN
$102B
$24.7M 0.5%
883,281
-6,600
-0.7% -$178K
HUBB icon
40
Hubbell
HUBB
$24.4B
$22.2M 0.45%
53,584
-2,181
-4% -$789K
AMZN icon
41
Amazon
AMZN
$2.44T
$22.1M 0.45%
122,601
+104,160
+565% +$17.4M
AAPL icon
42
Apple
AAPL
$4.97T
$20.5M 0.42%
119,779
-13,689
-10% -$2.49M
WMT icon
43
Walmart Inc
WMT
$909B
$19.9M 0.4%
330,862
-9,080
-3% -$520K
DOV icon
44
Dover
DOV
$26.7B
$19.8M 0.4%
111,727
-5,237
-4% -$843K
WMB icon
45
Williams Companies
WMB
$85.8B
$19.7M 0.4%
505,045
-450
-0.1% -$16K
WBD icon
46
Warner Bros
WBD
$64.3B
$19.2M 0.39%
2,195,267
+12,739
+0.6% +$123K
MRK icon
47
Merck
MRK
$322B
$17.3M 0.35%
130,813
-3,648
-3% -$450K
PKE icon
48
Park Aerospace
PKE
$720M
$16.7M 0.34%
1,005,147
– –
SYY icon
49
Sysco
SYY
$40.8B
$15.6M 0.32%
192,386
+300
+0.2% +$23.6K
ENB icon
50
Enbridge
ENB
$120B
$13.6M 0.28%
376,176
+400
+0.1% +$14.2K
1
2
3 4 5

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q1 2024 Portfolio in Review

As of Q1 2024, Beck Mack & Oliver held 190 positions worth $4.93B, up 15% from $4.3B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Beck Mack & Oliver deployed $193M of net new capital in Q1 2024, opening 7 new positions and adding to 53 existing holdings. Its largest new stake was Smith Douglas Homes: 142,029 shares worth $4.22M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $6.79M trimmed.

  • Beck Mack & Oliver's largest Q1 2024 buy was Smith Douglas Homes: 142,029 shares worth $4.22M.
  • Beck Mack & Oliver added most to Amazon in Q1 2024, an estimated $17.4M increase.
  • Beck Mack & Oliver's biggest Q1 2024 reduction was Teva Pharmaceuticals, cutting an estimated $6.79M.
  • Beck Mack & Oliver fully exited Blue Owl Capital in Q1 2024, selling an estimated $502K.
  • Beck Mack & Oliver's ten largest holdings make up 47% of its $4.93B portfolio in Q1 2024.
  • Beck Mack & Oliver opened 7 new positions and closed 11 in Q1 2024.
  • Beck Mack & Oliver's portfolio value rose 15% quarter-over-quarter to $4.93B.

Based on Beck Mack & Oliver's 13F filing for Q1 2024, filed 14 May 2024.